Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women

Obstetrics and Gynecology

Volumn 94, Issue 5, 1999, Pages 641-646

  MCGOWAN, JOSEPH P ^a   CRANE, MARILYN ^b   WIZNIA, ANDREW A ^b   BLUM, STEVE ^b  

^a Department of Medicine   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; EMBRYO; FEMALE; FETUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 0033231783     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-199911000-00001     Document Type: Article

References (8)

1. Connor EM, Sperling R, Gelfer, Kiselev P, Scott G, O'Sullivan MJ. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
2. Stiehm ER, Lambert JS, Mofenson LM, Bethel J, Whitehouse J, Nugent R, et al. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185. J Infect Dis 1999;179:567-75.
3. Centers for Disease Control and Prevention. Report of the NIH Panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep 1998;47(RR-5):1-80.
4. Centers for Disease Control and Prevention. Public Health Service Task Force for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health, and for reducing perinatal HIV-1 transmission in the United States. MMWR Morb Mortal Wkly Rep 1998;47(RR-2):1-30.
5. Lorenzi P, Spicher VM, Laubereaub B, Hirschel B, Kind C, Rudin C, et al. Antiretroviral therapies in pregnancies: Maternal, fetal and neonatal effects. AIDS 1998;12:F241-7.
6. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Morb Mortal Wkly Rep 1998;(RR-4):5-6.
7. Cao Y, Krogstad P, Korber RA, Koup RA, Muldon M, Macken C, et al. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel project for the prevention of HIV transmission from mother to infant. Nat Med 1997;3:549-52.
8. Hecht FM, Grant RM, Petroupoulos CJ, Dillon B, Chesney MA, Tian H, et al. Sexual transmission of an HIV-1 variant resistant to multiple reverse transcriptase and protease inhibitors. N Engl J Med 1998;339:307-11.